Cibc Private Wealth Group, LLC Tiziana Life Sciences LTD Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 6,000 shares of TLSA stock, worth $4,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000
Previous 6,000
-0.0%
Holding current value
$4,440
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
32Shares Held
1.96MCall Options Held
19.2KPut Options Held
0-
Sanctuary Advisors, LLC Indianapolis, IN908KShares$671,6330.01% of portfolio
-
Geode Capital Management, LLC Boston, MA219KShares$161,8230.0% of portfolio
-
Hsbc Holdings PLC London, X0115KShares$85,3700.0% of portfolio
-
Morgan Stanley New York, NY110KShares$81,2120.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il104KShares$77,1750.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $75.7M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...